Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The last time I wrote about Zomedica (NASDAQ: ZOM ) ZOM stock it had crossed under $1. Investors were nervous about its plans to sell its Truforma diagnostic platform for detecting thyroid disorders in companion an...
The heightened rate of pet adoption during the COVID-19 pandemic has increased the sale of pet food, medication, and diagnostic devices over the past year. This trend is likely to continue as most businesses move to a hybrid work schedule permanently, given its benefits, and people continue t...
On May 17th, institutional investment managers with more than $100 million AUM had to disclose their positions at the end of Q1 2021. I curated a list of some of the best-performing hedge funds and looked into their holdings at the end of March 2021. Several common themes appear w...
IDEXX Laboratories (IDXX), Generac Holdings (GNRC), and MKS Instruments (MKSI) are 3 growth stocks with major potential. Should you buy the dip? There has been a shift away from growth stocks toward value stocks in recent months. This shift is the result of growth stocks soaring to the po...
When #institutionalinvestors make decisions to buy and sell #stocks they normally want to keep it quiet. However, if we pay close attention we can see what is going on, and make good decisions.. The Idexx Laboratories (NASDAQ: IDXX) report below can help you understand how...
Image source: The Motley Fool. IDEXX Laboratories Inc (NASDAQ: IDXX) Q1 2021 Earnings Call May 4, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: IDEXX Laboratories Inc (IDXX) Q1 2021 Earnings Call Transcript
IDEXX Laboratories, Inc. (IDXX) Q1 2021 Earnings Conference Call May 4, 2021 8:30 A.M. ET Company Participants Brian McKeon - Chief Financial Officer Jay Mazelsky - President and Chief Executive Officer Conference Call Participants Michael Ryskin - Bank of America Erin Wright - Credit Suisse ...
IDEXX Laboratories (IDXX) posted first-quarter results that beat Wall Street analysts, helped by the strength in its Companion Animal Group ("CAG") Diagnostics segment, and raised its full-year forecast.The company raised its full-year revenue forecast to $3,105M - $3,160M vs. consensus ...
IDEXX Laboratories (IDXX): Q1 GAAP EPS of $2.35 beats by $0.64.Revenue of $778M (+24.2% Y/Y) beats by $39.57M.Gross margin of 60.5% vs. consensus of 58.3%.Operating margin of 31.8% compared to estimate of 26.2%.The company, increases 2021 revenue guidance to $3,1...
IDEXX Laboratories (NASDAQ:IDXX) is scheduled to announce Q1 earnings results on Tuesday, May 4th, before market open.The consensus EPS Estimate is $1.73 and the consensus Revenue Estimate is $738.43M (+17.9% Y/Y).Over the last 2 years, IDXX has beaten EPS estimates 100% of the time and has b...
News, Short Squeeze, Breakout and More Instantly...
IDEXX Laboratories Inc. Company Name:
IDXX Stock Symbol:
NASDAQ Market:
IDEXX Laboratories Inc. Website:
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will now host its 2024 second quarter conference call and webcast at 9:00 am ET on Tuesday, August 6, 2024, to minimize conflicts with other industry earnings announcements. Individuals can access a live ...
IDEXX Releases 2023 Corporate Responsibility Report, Highlighting Progress Against Its Goals PR Newswire WESTBROOK, Maine , July 30, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today published i...
2024-07-19 00:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...